Efficacy of major chlamydia drug confirmed

ScienceDaily, December 23, 2015

In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia.

In a study published Dec. 24 in the New England Journal of Medicine, the research team compared two of the most commonly used medications for urogenital chlamydia.

Read more here

Pilot study suggests that PrEP for other STIs might work

nam, 12 February 2015

A small pilot study using a daily dose of the antibiotic doxycycline as pre-exposure prophylaxis  against sexually transmitted infections has found that a group of HIV-positive gay men taking doxycycline was more than 70% less likely to be infected with an STI than men given financial incentives to avoid STIs, a significant difference.

Read more here